TMCI

Treace Medical Concepts, Inc.

• TipRanks·5d ago

  Treace Medical Shareholders Back Directors, Pay and Auditor

• PUBT·5d ago

  Treace Medical Concepts shareholders elect Class II directors at annual meeting

• TipRanks·05/11 17:48

  Treace Medical participates in a conference call with BTIG

• TipRanks·05/11 13:30

  Analysts Conflicted on These Healthcare Names: Treace Medical Concepts (TMCI), NewAmsterdam Pharma Company (NAMS) and LENSAR (LNSR)

• TipRanks·05/11 11:51

  Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (CCRN), Molina Healthcare (MOH) and Treace Medical Concepts (TMCI)

• Simply Wall St·05/09 00:45

  Treace Medical Concepts (TMCI) Q4 Loss Narrowing To US$0.15 EPS Tests Bearish Narratives

• Seeking Alpha·05/08 15:03

  Treace reaffirms 2026 revenue of $202M-$212M while targeting $300M TAM expansion in Q3 launches

• TipRanks·05/08 13:37

  Treace Medical backs FY26 revenue view $202M-$212M, consensus $205.92M

• Seeking Alpha·05/08 11:22

  Treace Medical Concepts GAAP EPS of -$0.28 beats by $0.03, revenue of $47.2M beats by $1.15M

• Reuters·05/08 11:13

  Treace Medical Q1 revenue falls 10%, less than expected

• TipRanks·05/08 11:10

  Treace Medical reports Q1 EPS (28c), consensus (31c)

• Benzinga·05/08 11:07

  Treace Medical Concepts Raises FY2026 Sales Guidance from $200.000M-$212.000M to $202.000M-$212.000M vs $205.920M Est

• Benzinga·05/08 11:06

  Treace Medical Concepts Q1 EPS $(0.28) Beats $(0.31) Estimate, Sales $47.198M Beat $45.960M Estimate

• PUBT·05/08 11:06

  Treace Medical Q1 net loss widens to $18 million; revenue drops 10% to $47.2 million

• Dow Jones·05/08 11:06

  *Treace Medical Concepts Backs 2026 Rev $202M-$212M >TMCI